VEGF, CD171 and CD79B: Key Antibody and Protein Tools for Angiogenesis, Neural Development and B-Cell Immunology Research
High-quality, highly specific antibodies are indispensable tools for dissecting disease mechanisms and advancing therapeutic development. Among the vast array of cell-surface and secreted proteins, VEGF, CD171, and CD79B have emerged as critical targets in angiogenesis, neuro-oncology, and B-cell immunology, respectively. Monoclonal antibodies and recombinant proteins against these markers enable precise detection, functional interrogation, and therapeutic targeting—driving breakthroughs from fu
Read full blog
WeChat